Posted by Michael Wonder on 26 Feb 2019
Are low-priced drugs becoming an endangered species?
26 February 2019 - The price of Canada’s top-selling patented drugs has increased by 800 per cent over 10 years.
A single phrase in a federal government report released last week made a dire prediction about the future of drug prices: "Lower-cost medicines may become the exception rather than the norm."
That warning, in its dry bureaucratic language, was contained in a new report from Canada's drug price monitoring agency, the Patented Medicine Prices Review Board. The report explores the "market entry dynamics" of new drugs approved in 2016 and 2017 in Canada, the U.S. and the European Union.
